Elsevier

The Lancet

Volume 379, Issue 9815, 11–17 February 2012, Page 519
The Lancet

Correspondence
Research into end-of-life cancer care—investment is needed

https://doi.org/10.1016/S0140-6736(12)60230-XGet rights and content

References (4)

There are more references available in the full text version of this article.

Cited by (25)

  • Integration of oncology and palliative care: a Lancet Oncology Commission

    2018, The Lancet Oncology
    Citation Excerpt :

    This small amount is often spent across multiple projects, meaning that the support for evaluative trials, or new palliative treatments, is insufficient. These figures are similar to those reported for 2010, when only 0·24% of cancer research spending in the UK went to palliative or end-of-life care, although the overall funding for research in cancer increased slightly.180 Similarly, in the USA, of the National Cancer Institute's total appropriation for 2010 of US$5 billion, only 1% was awarded to palliative care research.180

  • Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission report

    2018, The Lancet
    Citation Excerpt :

    The Lancet Commission on Essential Medicines put forward similar proposals, and our Commission strongly supports these recommendations and suggests working jointly, at least with respect to access to medicines for pain relief.336 Despite the increasing demand for palliative care and its documented health, social, and economic benefits, a very small proportion of resources for health-care research—just 0·2% of total resources for cancer research in the UK and 1% of the 2010 total appropriation of the US National Cancer Institute—is devoted to palliative care.337 Basic, clinical, and health-systems research could improve the effectiveness and selection of medicines and interventions involved in palliative care, disseminate generalisable findings, and identify practices and models that could be implemented and scaled up in LMICs.185,338

  • Palliative care: When and how, and what are the implications for global cancer policy?

    2016, Journal of Cancer Policy
    Citation Excerpt :

    In order to answer these questions, investment in research is necessary. Currently in the UK, less than 0.5% of the cancer research budget is allocated to research that aims to improve end-of-life cancer care [52]. In 2010 this money was allocated in 48 separate awards, providing an average of just £25,000 per award.

  • Failures in Health and Social Care: Governance and Culture Change

    2023, Failures in Health and Social Care: Governance and Culture Change
View all citing articles on Scopus
View full text